Although the European Medicines Agency (EMA) says that for now there is no evidence that a third booster dose would be needed, an EU source told EURACTIV that such a scenario is “highly likely”.
The same source does not rule out the possibility to have this third dose against COVID-19 even within 2021, depending on the progress of different variants.
US pharmaceutical company Pfizer will soon seek EMA’s approval Agency for a third vaccine booster dose, which it says can give up to 10 times more protection.
The Commission has already made a deal with the company to purchase 1.8 billion doses to administered by 2023.
Israel said on Sunday it will begin offering a third dose of Pfizer’s vaccine to adults with weak immune systems but it was still weighing whether to make the booster available to the general public, Reuters reported.
(Sarantis Michalopoulos | EURACTIV.com)